C. Jones

发表

Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.

B. Scheithauer, J. O'fallon, E. Shaw, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-in-human phase I study evaluating the safety, pharmacokinetics (PK), and intratumor pharmacodynamics (PD) of the novel, oral, ATP-competitive Akt inhibitor GDC-0068.

C. Jones, J. Baselga, J. Tabernero, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of DJ-927, an oral tubulin depolymerization inhibitor, in the treatment of metastatic colorectal cancer.

C. Jones, M. Saif, P. Hoff, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution’s Experience Over 40 Years

C. Jones, R. Zlotecki, A. Spiguel, 2019, American journal of clinical oncology.

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.

A. Garden, C. Jones, J. Cooper, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab.

Christopher U. Jones, K. Ang, C. Jones, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.

R K Valicenti, M Machtay, C. Jones, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network.

C. Jones, J. Zehnder, J. Eickhoff, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A Pilot Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Estrogen and/or Progesterone Receptor Positive Breast Cancer.

C. Jones, K. Bland, A. Forero, 2009 .

Clinical combination of the MEK inhibitor GDC-0973 and the PI3K inhibitor GDC-0941: A first-in-human phase Ib study testing daily and intermittent dosing schedules in patients with advanced solid tumors.

C. Jones, A. D. de Crespigny, M. Belvin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.

C. Jones, A. Hildesheim, A. Jurado, 1992, Cancer research.

Phase I II T rial C omparing W hole-Pelvic V ersus P rostate-Only Radiotherapy a nd N eoadjuvant V ersus A djuvant C ombined Androgen S uppression: R adiation T herapy O ncology Group 9 413

C. Jones, M. Desilvio, M. Roach, 2003 .